The MAPK kinase-deficient M Nozzles are resistant to activated protein collagen Induced arthritis, indicating that the inhibitor can MAPKAP2 therapeutic value in the treatment of inflammatory diseases such as rheumatoid arthritis With. Crohn’s disease is a chronic and recurrent inflammatory disease of the bowel and removal, which erismodegib connected the entire digestive tract can be k. Like rheumatoid arthritis With, cytokines play an r Important in the pathogenesis, and to enable more than one of them is obtained p38MAPK Hte p38MAPK kinase activity t is h Frequently in the inflamed lining of the heart lon patients with Crohn’s disease was observed, see expression and activity Tk Nnte p38MAPK a useful marker to predict the response of the patient, such as Best Resistance to stero Be associated with the expression of p38MAPK nuclear cells in the lamina propria.
Differential activation of p38MAPK pathway has been in responders and non-responders to infliximab TNF DAPT chim Ren monoclonal Reported body, with stakeholders show an increased Hte phosphorylation of activating transcription factor 2 and the expression of heat shock protein 70th That psoriasis, a chronic inflammatory skin disease characterized by dry red silvery scales that only the surface-layers Chlichen the skin. Biopsies of psoriatic L Emissions levels of phosphorylated p38MAPK in the cytoplasm and nucleus of epidermal cells obtained Ht. The Kinaseaktivit t Of p38, p38 and p38 isoforms δ in these L Dispersions obtained Ht, but decreased by one Much the same level as in the skin not aufl St psoriasis involved present. This suggests an r P38MAPK in the pathogenesis of this disease.
In line with this hypothesis fumaric Acid esters, which are sometimes used in the treatment of psoriasis, effectively inhibit the activity of t of the target p38MAPK mitogen and stress activated protein kinase 1 and expression MSK2 and MSK1 is MSK2 h Frequently in psoriatic L Emissions, where they thought to contribute to the production of proinflammatory cytokines increased ht. The Asthma is a chronic lung disease. By inflammation of the airways, which causes the bronco constriction, wheezing and coughing It is characterized by infiltration of lung tissue by inflammatory cells, which is caused largely by type 2 helper T-cells, mast cells and eosinophils. This is in contrast with RA, CD, and psoriasis, wherein the inflammatory response, in particular by Th1 and Th17 helper T occurs.
p38MAPK is an important regulator of Th2-dependent-dependent cytokine, IL 4 and IL 13, monocyte chemotactic protein 1 in lung epithelial cells and mast cells produce IL 9th In addition, studies in knockout M Usen MAPKAP2 MAPKAP2 an important substrate for p38MAPK behind asthma, suggesting that this may be a useful target for the development of new treatments for asthma. Although most studies show that asthma is Th2 dependent Ngig, there is increasing evidence that p38MAPK also involved in Th1 cytokines in asthma. p38MAPK also an r in the production of several cytokines that are enabled in allergic asthma. p38MAPK in cardiovascular, cardiovascular disease is a major cause of morbidity t and mortality t in the United K Kingdom and includes several different conditions, including normal arteriosclerosis, hypertension-induced cardiac hypertrophy, myocardial infarction and cerebrovascular re diseases .